Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COMMERCIAL PACKAGING AGREEMENTCommercial Packaging Agreement • November 6th, 2018 • Nabriva Therapeutics PLC • Pharmaceutical preparations • Pennsylvania
This Commercial Packaging Agreement (“Agreement”) is made as of this 26 day of December, 2017 (“Effective Date”), by and among Zavante Therapeutics, Inc., a Delaware corporation, with a place of business at 11750 Sorrento Valley Blvd., Suite 250, San Diego CA 92121 (“Zavante”), and AndersonBrecon Inc., an Illinois corporation, doing business as PCI of Illinois , with a place of business at 4545 Assembly Drive, Rockford, IL 61109 (together, “PCI”).
Certain information identified by [***] has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. COMMERCIAL PACKAGING AGREEMENTCommercial Packaging Agreement • June 25th, 2021 • Blue Water Acquisition Corp. • Biological products, (no disgnostic substances) • Pennsylvania
This Commercial Packaging Agreement (“Agreement”) is made as of this 26th day of June, 2014 (“Effective Date”), by and among Clarus Therapeutics, Inc., a Delaware corporation, with a place of business at 555 Skokie Blvd., Suite 340, Northbrook, IL 60062 (“Client”), and Packaging Coordinators, LLC, a Delaware limited liability company, doing business as PCI of Philadelphia and PCI of Woodstock, with a place of business at 3001 Red Lion Road, Philadelphia, Pennsylvania 19114, USA (“PCI”).
COMMERCIAL PACKAGING AGREEMENTCommercial Packaging Agreement • February 27th, 2020 • Aimmune Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Commercial Packaging Agreement (“Agreement”) is made as of this 11th day of November, 2019 (“Effective Date”), by and among Aimmune Therapeutics, Inc., a Delaware corporation, with a place of business at 8000 Marina Blvd., Suite 300, Brisbane, CA 94005 and/or any Affiliate as may become a party to this Agreement or subsequent assignee (“Client”), and AndersonBrecon Inc., an Illinois corporation, doing business as PCI of Illinois, with a place of business at 4545 Assembly Drive, Rockford, IL 61109 (“PCI-US”), and Millmount Healthcare Limited, with an address at Block 7, City North Business Campus, Stamullen Hall, Stamullen, Co. Meath, Ireland (“PCI-Ireland” and, together with PCI-US, “PCI”).
COMMERCIAL PACKAGING AGREEMENTCommercial Packaging Agreement • April 25th, 2017 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • Delaware
This Commercial Packaging Agreement (“Agreement”) is made as of this 12th day of December, 2016 (“Effective Date”), by and among Neurocrine Biosciences Inc., a corporation organized under the laws of Delaware, with offices at 12780 El Camino Real, San Diego, California, 92130, USA (“Client”) and AndersonBrecon Inc., an Illinois corporation, doing business as PCI of Illinois , with a place of business at 4545 Assembly Drive, Rockford, IL 61109 ( “PCI”).
